AngelosPBedrosianIEuhusDMHerrmannVMKatzSJPusicAContralateral prophylactic mastectomy: challenging considerations for the surgeonAnn Surg Oncol.201522103208–321210.1245/s10434-015-4758-y4836440
5.
BarnettMLGrayJZinkAJenaACoupling policymaking with evaluation—the case of the opioid crisisN Engl J Med20173772306–230910.1056/NEJMp1710014
6.
BradyJWunschHDiMaggioCLangBHGiglioJLiGPrescription drug monitoring and dispensing of prescription opioidsPublic Health Rep20141292139–14710.1177/0033354914129002073904893
7.
CarlsonRGNahhasRWMartinsSSDaniulaityteRPredictors of transition to heroin use among initially non-opioid dependent illicit pharmaceutical opioid users: a natural history studyDrug Alcohol Depend.2016160127–13410.1016/j.drugalcdep.2015.12.0264767561
8.
CDC Wonder2017AtlantaUS Department of Health and Human Services, CDC
9.
2015 National Survey on Drug Use and Health: Detailed Tables2016RockvilleSubstance Abuse and Mental Health Services Administration
10.
Centers for MedicareMedicaid Services (CMS)Medicare and Medicaid programs; hospital conditions of participation: quality assessment and performance improvement. Final ruleFed Regist200368163435–3455
Chan LS, Elabiad M, Zheng L, et al. A medical staff peer review system in a public teaching hospital—an internal quality improvement tool. J Healthc Qual. 2014;36(1):37–44.
13.
ChangHYLyapustinaTRutkowLImpact of prescription drug monitoring programs and pill mill laws on high-risk opioid prescribers: a comparative interrupted time series analysisDrug Alcohol Depend.20161651–810.1016/j.drugalcdep.2016.04.0334985620
Credentialing and Privileging—Requirements for Physician Assistants and Advanced Practice Registered Nurses. The Joint Commission.
17.
Crosswalk to Performance Improvement. The Joint Commission.
18.
DavisCSCarrDHSelf-regulating profession? Administrative discipline of “pill mill” physicians in FloridaSubst Abus2017383265–26810.1080/08897077.2017.1316812
19.
DelcherCWagenaarACGoldbergerBACookRLMaldonado-MolinaMMAbrupt decline in oxycodone-caused mortality after implementation of Florida's prescription drug monitoring programDrug Alcohol Depend201515063–6810.1016/j.drugalcdep.2015.02.010
Deyo-SvendsenPMRAlbrightJKSchillingKAPalmerKBA systematic approach to clinical peer review in a critical access hospitalQual Manag Health Care2016254213–21810.1097/QMH.00000000000001135054974
22.
EdwardsMTClinical peer review program self-evaluation for US hospitalsAm J Med Qual2010256474–48010.1177/1062860610371224
23.
FinleyEGarciaARosenKMcGearyDPughMJPotterJSEvaluating the impact of prescription drug monitoring program implementation: a scoping reviewBMC Health Serv Res201717142010.1186/s12913-017-2354-55477729
24.
FudinJAtkinsonTJOpioid prescribing levels off, but is less really more?Pain Medicine2014152184–18710.1111/pme.12340
García MC, Dodek AB, Kowalski T, et al. Declines in opioid prescribing after a private insurer policy change—Massachusetts, 2011–2015. MMWR Morb Mortal Wkly Rep. 2016;65:1125–1131.
GrantDAlfredKCSanctions and recidivism: an evaluation of physician discipline by state medical boardsJ Health Polit Policy Law2007325867–88510.1215/03616878-2007-033
29.
GriggsCWeinerSFeldmanJPrescription drug monitoring programs: examining limitations and future approachesWest J Emerg Med201516167–7010.5811/westjem.2014.10.241974307729
30.
HaegerichTMPaulozziLJMannsBJJonesCMWhat we know, and do not know, about the impact of state policy and systems-level interventions on prescription drug overdoseDrug Alcohol Depend201414534–4710.1016/j.drugalcdep.2014.10.0016557270
31.
HaffajeeRPreventing opioid misuse with prescription drug monitoring programs: a framework for evaluating the success of state public health lawsHastings Law Journal20166761621–1694
32.
HarrisJAByhoffEVariations by state in physician disciplinary actions by US medical licensure boardsBMJ Qual Saf2017263200–20810.1136/bmjqs-2015-004974
33.
HawkKD'OnofrioGFiellinDAPast-year prescription drug monitoring program opioid prescriptions and self-reported opioid use in an emergency department population with opioid use disorderAcad Emerg Med2018255508–51610.1111/acem.13352
LawMTHansenZKMedical licensing board characteristics and physician discipline: an empirical analysisJ Health Polit Policy Law201035163–9310.1215/03616878-2009-041
39.
Leibert M. Performance of state medical boards: implications for hospitals and health systems. Hosp Top. 2010;88:4:107–115.
Lyapustina T, Rutkow L, Chang HY, et al. Effect of a “pill mill” law on opioid prescribing and utilization: the case of Texas. Drug Alcohol Depend. 2016;159:190–197.
42.
MaughanBBachhuberMAMitraNStarrelsJLPrescription monitoring programs and emergency department visits involving opioids, 2004–2011Drug Alcohol Depend2015156282–28810.1016/j.drugalcdep.2015.09.0244911899
43.
MearaEHorwitzJPowellWState legal restrictions and prescription-opioid use among disabled adultsN Engl J Med201637544–5310.1056/NEJMsa15143874985562
44.
MillerKEPhysician attitudes a barrier to pain managementAm Fam Physician200062102317–2318
45.
N.J. Stat. Ann. § 24:21–15.1.
46.
N.Y. Pub. Health Law § 230.
47.
N.Y. Pub. Health Law § 230; § N.Y. Educ. Law § 6532.
48.
N.Y. Pub. Health Law § 3309-a(3).
49.
N.Y. Pub. Health Law § 3331(5)(b).
50.
N.Y. Pub. Health Law § 3331(5).
51.
N.Y. Pub. Health Law Article 33.
52.
NamYHSheaDGShiYMoranJRState prescription drug monitoring programs and fatal drug overdosesAm J Manag Care2017235297–303
53.
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse. Phillips JK, Ford MA, Bonnie RJ, editors. Pain management and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid use. Washington (DC): National Academies Press (US) 2017. 4, Trends in opioid use, harms, and treatment. Available from https://www.ncbi.nlm.nih.gov/books/NBK458661. Accessed 10 Sept 2018.
NevenDPaulozziLHowellDA randomized controlled trial of a citywide emergency department care coordination program to reduce prescription opioid related emergency department visitsJ Emerg Med2016515498–50710.1016/j.jemermed.2016.06.0575568539
56.
NolanSWBurkardJFClarkMJDavidsonJEAganDLEffect of morbidity and mortality peer review on nurse accountability and ventilator-associated pneumonia ratesJ Nurs Adm20104093748310.1097/NNA.0b013e3181ee427b
OsbornSRYuJWilliamsBVasilyadisMBlackmoreCCChanges in provider prescribing patterns after implementation of an emergency department prescription opioid policyJ Emerg Med2017524538–54610.1016/j.jemermed.2016.07.120
59.
PaoneDTuazonEKattanJDecrease in rate of opioid analgesic overdose deaths—Staten Island, New York City, 2011–2013MMWR Morb Mortal Wkly Rep20156418491–4944584824
60.
PentiBLiebschutzJMKopczaBXuanZOdellCSaperRNovel peer review method for improving controlled substance prescribing in primary careJ Opioid Manag2016124269–27910.5055/jom.2016.0342
61.
N.Y. Pub. Health Law § 3343-a; 10 NYCRR § 80.63; Fla. Stat. § 893.055 (2018); 37 Tex. Admin. Code §§ 13.71–86 (West 2005).
62.
Physician and Physician Assistants Disciplinary and Other Actions. Department of Health. NY State: Department of Health. Revised July 2012.
63.
Physician Information (Arthur Mercado). NY State: Department of Health.
64.
Physician Information (Gregory Denzel). NY State: Department of Health.
65.
Physician Information (Liviu Nastase). NY State: Department of Health.
66.
PomerleauACNelsonLSHoppeJASalzmanMWeissPSPerroneJThe impact of prescription drug monitoring programs and prescribing guidelines on emergency department opioid prescribingPain Med2017185889–897
67.
PorterJHershelJAddiction rare in patients treated with narcoticsN Engl J Med1980302123
68.
Quality Assessment and Performance Improvement (QAPI) Program Description. Peach State Health Plan: 2017.
69.
ReismanRMShenoyPJAtherlyAJFlowersCRPrescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacySubst Abuse2009341–513865068
70.
Roe v. Wade and the right to abortion. National Women's Law Center. January 18, 2018.
71.
RoseMEAre prescription opioids driving the opioid crisis? Assumptions vs. factsPain Medicine2017194793–80710.1093/pm/pnx048
72.
S.D. Codified Laws § 34-23A-10.1; Mo. Ann. Stat. § 188.039.
73.
SaundersKShortreedSThielkeSEvaluation of health plan interventions to influence chronic opioid therapy prescribingClin J Pain2015319820–8294620063
SoelbergCDBrownREJrDu VivierDMeyerJERamachandranBKThe US opioid crisis: current federal and state legal issuesAnesth Analg201712551675–168110.1213/ANE.0000000000002403
76.
SpoonerLFernandesKMartinsDHigh-dose opioid prescribing and opioid-related hospitalization: a population-based studyPLOS One2016121e0170834
State Opioid Prescribing Policy: Florida. Florida Academy of Pain Medicine.
79.
Substance Abuse and Mental Health Services AdministrationPrescription drug monitoring programs: a guide for healthcare providersIn Brief201710110.1016/j.dib.2016.11.054
80.
SunBCCharlesworthCJLupulescu-MannNEffect of automated prescription drug monitoring program queries on emergency department opioid prescribingAnn Emerg Med2018713337–34710.1016/j.annemergmed.2017.10.023
81.
Tex. Health & Safety Code Ann. § 171.012; Wis. Stat. Ann. § 253.10.
82.
Texas Medical Association House of Delegates: Responsible Opioid Prescribing for Pain Management. Texas Pain Society. Available from https://www.texaspain.org/assets/resolution313.pdf. Accessed 10 Sept 2018.
83.
TriccoACIversNMGrimshawJMEffectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysisLancet201237998332252–226110.1016/S0140-6736(12)60480-2
84.
Understanding New York's Medical Conduct Program—Physician Discipline. NY State: Department of Health. Revised March 2016. Available from https://www.health.ny.gov/publications/1445. Accessed 10 Sept 2018.
85.
VyasDHozainAEClinical peer review in the United States: history, legal development and subsequent abuseWorld J Gastroenterol201420216357–636310.3748/wjg.v20.i21.63574047321
WaisbrenSJThe opioid epidemic and the Minnesota Board of Medical PracticeMinn Med201699339–41
88.
Webster L. The pain epidemic versus the opioid crisis; in Worley SL. New directions in the treatment of chronic pain: National pain strategy will guide prevention, management, and research. PT. 2016;41:107–115.
89.
Wollschlaeger v. Governor, Fla., 848 F.3d 1293 (11th Cir. 2017).